Answers are grounded in this paper and cite their sources.
and GTPase-activating proteins (GAPs), which catalyse GTP hydrolysis and inactivation (7).Oncogenic somatic mutations in the H-Ras gene aff ect GAP-mediated hydrolysis and keep H-Ras in a constitutively active state (8, 9), which in turn leads to hyper-activation of its downstream pathways.In CS, germline mutations aff ect similar residues as the somatic oncogenic mutations, with the Gly12 to serine (G12S) substitution identifi ed in more than 80% of patients.Other mutations (e.g., G12V, G12D) are rare, and the aff ected patients usually develop a stronger phenotype which results in postnatal fatality (10-12).Research on CS was advanced by the creation of a mouse model harbouring an H-Ras G12V germline mutation.Th is mouse phenocopies some features of the CS patients: craniofacial dysmorphia, skeletal abnormalities, hypertrophic cardiomyopathy, neurological and behavioural alterations (13,14).Using another mouse model harbouring the same mutation, an essential role for H-Ras in tooth development was established (15).At the same time, a combination of in vitro and in vivo studies (using in utero electroporation of embryos), proved that neurogenesis is impaired by H-Ras mutations in cortical progenitor cells.
No takes yet. Share an insight, caveat, or question.
Chennappan et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: